Integra LifeSciences Holdings Corporation (IART): Price and Financial Metrics
IART Stock Summary
- IART has a higher market value than 75.01% of US stocks; more precisely, its current market capitalization is $5,858,649,050.
- Price to trailing twelve month operating cash flow for IART is currently 28.74, higher than 81.22% of US stocks with positive operating cash flow.
- In terms of twelve month growth in earnings before interest and taxes, Integra Lifesciences Holdings Corp is reporting a growth rate of 44.75%; that's higher than 78.58% of US stocks.
- Stocks that are quantitatively similar to IART, based on their financial statements, market capitalization, and price volatility, are DCI, NUVA, PNR, BRC, and ASTE.
- IART's SEC filings can be seen here. And to visit Integra Lifesciences Holdings Corp's official web site, go to www.integralife.com.
IART Stock Price Chart Interactive Chart >
IART Price/Volume Stats
|Current price||$70.22||52-week high||$71.34|
|Prev. close||$69.92||52-week low||$42.12|
|Day high||$71.07||Avg. volume||369,796|
|50-day MA||$68.27||Dividend yield||N/A|
|200-day MA||$56.68||Market Cap||5.92B|
Integra LifeSciences Holdings Corporation (IART) Company Bio
Integra LifeSciences develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, orthopedics, and general surgery. The company operates in five segments: U.S. Neuro-surgery; U.S. Extremities; U.S. Instruments; U.S. Spine and Other; and International. The company was founded in 1989 and is based in Plainsboro, New Jersey.
IART Latest News Stream
|Loading, please wait...|
IART Latest Social Stream
View Full IART Social Stream
Latest IART News From Around the Web
Below are the latest news stories about Integra Lifesciences Holdings Corp that investors may wish to consider to help them evaluate IART as an investment opportunity.
Integra LifeSciences (IART) has enjoyed a good run since the fall of 2020, rising more than 40% and handily beating the broader med-tech space. It seems as though investors have really liked the company’s decision to exit orthopedics and reallocate capital toward regenerative medicine, and that makes sense as it...
PRINCETON, N.J., April 08, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release first quarter 2021 financial results on Wednesday, April 28, 2021 prior to market open. In conjunction with the earnings release, Integra’s management team will host a conference call at 8:30 a.m. ET. The live call is accessible by dialing (800) 353-6461 and using the passcode 8109382. A simultaneous webcast of the call will be available via the Company’s website at www.integralife.com. A webcast replay of the call can be accessed through the Investor Relations homepage of Integra's website at www.integralife.com. A replay of the call will be available until May 8, 2021 by dialing (888) 203-1112 and using the passcode 810...
One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...
BTIG Stick to Their Buy Rating for Integra Lifesciences Holdings Corp.
Acellular Dermal Matrices Market Major Players Analysis Zimmer Biomet, Stryker Corporation, Staumann, Allergan, Inc., Conmed, Integra LifeSciences Corporation, Aziyo Biologics, Hospital Innovations, Medtronic, Inc., Synthes, Inc.
Acellular Dermal Matrices Market report is an in-depth analysis study offered which explains necessary aspects like competition, segmentation, and regional growth in excessive detail. As a part of competitive analysis, the analysis study includes thorough company identification of leading players
IART Price Returns
Continue Researching IARTWant to do more research on Integra Lifesciences Holdings Corp's stock and its price? Try the links below:
Integra Lifesciences Holdings Corp (IART) Stock Price | Nasdaq
Integra Lifesciences Holdings Corp (IART) Stock Quote, History and News - Yahoo Finance
Integra Lifesciences Holdings Corp (IART) Stock Price and Basic Information | MarketWatch
Get Free Updates
Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!